The Role of Thymidylate Synthase As A Molecular Biomarker

Clinical Cancer Research

Volumn 10, Issue 2, 2004, Pages 411-412

  DiPaolo, Antontello ^a   Chu, Edward ^b,c  

^a UNIVERSITY OF PISA   (Italy)

^b YALE CANCER CENTER   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; BIOLOGICAL MARKER; CAPECITABINE; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; IRINOTECAN; OXALIPLATIN; THYMIDYLATE SYNTHASE;

ADVANCED CANCER; CANCER CHEMOTHERAPY; COLORECTAL CANCER; DRUG RESPONSE; EDITORIAL; GENE; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; TS GENE;

BIOLOGICAL MARKERS; COLORECTAL NEOPLASMS; HUMANS; THYMIDYLATE SYNTHASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0842268403     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-1198-03     Document Type: Editorial

References (8)

1. Bertino, J. R., and Banerjee, D. Is measurement of expression of thymidylate synthase to determine suitability for treatment with 5-fluoropyrimidines ready for prime time? Clin. Cancer Res., 9: 1235-1239, 2003.
2. Horie, N., Aiba, H., Ogaro, K., Hojo, H., and Takeishi, K. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct. Funct., 20: 191-197, 1995.
3. Marsh, S., and McLeod, H. L. Thymidylate synthase pharmacogenetics in colorectal cancer. Clin. Colorectal Cancer, 1: 1-4, 2001.
4. Zinzindohoue, F., Ferraz, J. M., and Laurent-Puig, P. Thymidylate synthase promoter polymorphism. J. Clin. Oncol., 19: 3442, 2001.
5. Kawakami, K., Ishida, Y., Danenberg, K. D., Omura, K., Watanabe, G., and Danenberg, P. V. Functional polymorphism of the thymidylate synthase gene in colorectal cancer accompanied by frequent loss of heterozygosity. Jpn. J. Cancer Res., 93: 1221-1229, 2002.
6. Uchida, K., Hayashi, K., Kawakami, K., Schneider, S., Yochim, J. M., Kuramochi, H., Takasaki, K., Danenberg, K. D., and Danenberg, P. V. Loss of heterozygosity at the thymidylate synthase (TS) locus on chromosome 18 affects tumor response and survival in individuals heterozygous for a 28-bp polymorphism in the TS gene. Clin. Cancer Res., 10: 433-439, 2004.
7. Chu, E., Schmitz, J. C., and Ju, J. Molecular regulation of expression of thymidylate synthase. In: A. L. Jackman (ed.), Cancer Drug Discovery and Development: Antifolate Drugs-Basic Research and Clinical Practice, pp. 397-408. Totowa, NJ: Humana Press, 1999.
8. Liu, J., Schmitz, J. C., Tai, N., Yan, W., Farrell, M., Bailly, M., Chen, T. M., and Chu, E. Thymidylate synthase as a translational regulator of cellular gene expression. Biochim. Biophys. Acta. 1587: 174-182, 2002.